Literature DB >> 2923624

Inhibition of osteoclastic acid phosphatase abolishes bone resorption.

M Zaidi1, B Moonga, D W Moss, I MacIntyre.   

Abstract

Osteoclastic acid phosphatase is a member of a widely-distributed class of iron-containing proteins with acid phosphatase activity. Antibodies raised against one member of this class cross-react with other members from the same or different species, but not with acid phosphatase isoenzymes of different types. When antibodies to one such protein, porcine uteroferrin, are added to medium in which rat osteoclasts are incubated on devitalised cortical bone, both bone resorption and acid phosphatase activity are markedly inhibited. Furthermore, addition of molybdate (an inhibitor of this class of acid phosphatases) also inhibits both bone resorption and enzyme activity. These observations strongly suggest a functional role for osteoclastic acid phosphatase in bone resorption.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2923624     DOI: 10.1016/0006-291x(89)92405-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

Review 1.  Acid phosphatases.

Authors:  H Bull; P G Murray; D Thomas; A M Fraser; P N Nelson
Journal:  Mol Pathol       Date:  2002-04

2.  Intracellular regulation of enzyme secretion from rat osteoclasts and evidence for a functional role in bone resorption.

Authors:  B S Moonga; D W Moss; A Patchell; M Zaidi
Journal:  J Physiol       Date:  1990-10       Impact factor: 5.182

3.  A quantitative cytochemical investigation of osteoclasts and multinucleate giant cells.

Authors:  M H Zheng; J M Papadimitriou; G C Nicholson
Journal:  Histochem J       Date:  1991-04

4.  Androgens regulate bone resorption activity of isolated osteoclasts in vitro.

Authors:  L Pederson; M Kremer; J Judd; D Pascoe; T C Spelsberg; B L Riggs; M J Oursler
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

5.  Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.

Authors:  M Sato; W Grasser; N Endo; R Akins; H Simmons; D D Thompson; E Golub; G A Rodan
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

6.  Inhibition of MSTN signal pathway may participate in LIPUS preventing bone loss in ovariectomized rats.

Authors:  Liang Tang; Yiting Kang; Shuxin Sun; Tingting Zhao; Wenxin Cao; Xiushan Fan; Jianzhong Guo; Lijun Sun; Dean Ta
Journal:  J Bone Miner Metab       Date:  2019-08-14       Impact factor: 2.626

7.  Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells.

Authors:  M J Oursler; L Pederson; L Fitzpatrick; B L Riggs; T Spelsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

8.  Clinical usefulness of serum tartrate-resistant acid phosphatase in Paget's disease of bone: correlation with other biochemical markers of bone remodelling.

Authors:  R Torres; C de la Piedra; A Rapado
Journal:  Calcif Tissue Int       Date:  1991-07       Impact factor: 4.333

9.  17 beta-estradiol suppresses gene expression of tartrate-resistant acid phosphatase and carbonic anhydrase II in ovariectomized rats.

Authors:  M H Zheng; T T Lau; R Prince; A Criddle; S Wysocki; M Beilharz; J M Papadimitriou; D J Wood
Journal:  Calcif Tissue Int       Date:  1995-02       Impact factor: 4.333

10.  The number of tartrate-resistant acid phosphatase-positive osteoclasts on neonatal mouse parietal bones is decreased when prostaglandin synthesis is inhibited and increased in response to prostaglandin E2, parathyroid hormone, and 1,25 dihydroxyvitamin D3.

Authors:  M J Marshall; I Holt; M W Davie
Journal:  Calcif Tissue Int       Date:  1995-03       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.